RCTS joins ALS Global

RCTS is an industry-leading provider of clinical testing services to the personal care and pharmaceutical industries. The acquisition of RCTS supports plans for growth and maintains ALS’ position as the global testing provider of choice for clinical testing services.

Strategically located in Dallas, Texas, USA, RCTS expands on the ALS clinical sites located in Torrance, California; Phoenix, Arizona; and Purchase, New York. RCTS will bring a diverse set of clinical services and capabilities to the ALS brand with major cosmetic, personal care, and pharmaceutical clients across the globe.

Managing Director and CEO, Raj Naran commented, “RCTS will enhance ALS’ existing life sciences operations, adding complementary clinical testing capabilities.”

 

RCTS introduces the EvaFace 3-D Imaging System!

RCTS, Inc.has acquired the Eotech EvaFACE 3D skin imaging system!

New cutting-edge technology now allows RCTS to analyze fine lines and wrinkles using the EvaFace 3-D Imaging System.  The EvaFACE system provides high-resolution images of both small facial skin areas as well as the full face to analyze changes of features such as wrinkles, roughness and volume (e.g., lips, under eye puffiness, sagginess) with micrometer accuracy.

The new EvaFACE system allows RCTS to offer a broader and more detailed range of testing services for the benefit of its sponsors as it relates to the efficacy of their skin care products..

Eotech 3D skin imaging systems are well established in Europe and the new EvaFACE system at RCTS marks an addition to the availability of these systems in the US to answer to the needs of organizations sourcing clinical dermatological safety and efficacy testing services.